- Home
- OCEAW vs ORN Comparison
OCEAW vs ORN Comparison
Compare OCEAW & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEAW
- ORN
- Stock Information
- Founded
- OCEAW N/A
- ORN 1994
- Country
- OCEAW United States
- ORN United States
- Employees
- OCEAW 7
- ORN N/A
- Industry
- OCEAW Biotechnology: Pharmaceutical Preparations
- ORN Military/Government/Technical
- Sector
- OCEAW Health Care
- ORN Industrials
- Exchange
- OCEAW Nasdaq
- ORN Nasdaq
- Market Cap
- OCEAW N/A
- ORN N/A
- IPO Year
- OCEAW 2021
- ORN 2007
- Fundamental
- Price
- OCEAW $0.03
- ORN $5.23
- Analyst Decision
- OCEAW
- ORN Strong Buy
- Analyst Count
- OCEAW 0
- ORN 3
- Target Price
- OCEAW N/A
- ORN $12.50
- AVG Volume (30 Days)
- OCEAW N/A
- ORN 459.2K
- Earning Date
- OCEAW N/A
- ORN 03-04-2025
- Dividend Yield
- OCEAW N/A
- ORN N/A
- EPS Growth
- OCEAW N/A
- ORN N/A
- EPS
- OCEAW N/A
- ORN N/A
- Revenue
- OCEAW N/A
- ORN $796,394,000.00
- Revenue This Year
- OCEAW N/A
- ORN $7.86
- Revenue Next Year
- OCEAW N/A
- ORN $11.33
- P/E Ratio
- OCEAW N/A
- ORN N/A
- Revenue Growth
- OCEAW N/A
- ORN 11.89
- 52 Week Low
- OCEAW N/A
- ORN $4.85
- 52 Week High
- OCEAW N/A
- ORN $12.12
- Technical
- Relative Strength Index (RSI)
- OCEAW N/A
- ORN 34.02
- Support Level
- OCEAW N/A
- ORN $5.71
- Resistance Level
- OCEAW N/A
- ORN $6.01
- Average True Range (ATR)
- OCEAW 0.00
- ORN 0.26
- MACD
- OCEAW 0.00
- ORN 0.03
- Stochastic Oscillator
- OCEAW 0.00
- ORN 19.30
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.